Glenhaven and Winston Hills Veterinary Hospitals- NSW
In this way, I can give my clients the answers immediately so they don’t have to be called back for treatment. We can implement appropriate action at the initial consultation. It is a more effective use of my time, and their’s. For instance, we can treat for Giardiasis if present; similarly, we can diagnose a wide range of diseases and initiate treatment straight away.
I am particularly excited by the antibody titre testing for Distemper, Parvovirus and Hepatitis. These Biotech tests, augmented by the digital reader, give us an almost immediate answer for our clients to help us decide whether their dogs need booster vaccination. We can advise them of their pets’ level of protection and tailor their vaccinal needs. We can offer annual “patient-side” titre tests for these core diseases and instigate or avoid vaccination as appropriate. Until now, our clients have not wanted to wait for the results to come back from the other side of the country (or the other side of the world), and have mostly elected to vaccinate not knowing whether or not their pet required a booster. With the advent of these in-house titre tests we can provide a new standard of excellence in veterinary practice, and at the same time ensure client retention and growth of the practice. Income we lost from vaccinating every three years with triennial vaccines can be replaced with revenue from annual core disease antibody tests. These antibody tests can realistically be incorporated into an annual health check, with answers available while the client and dog are still with us. We record the result on the patient’s file and the year to year trends are a valuable offering to our clients.
Head Veterinarian - SPCA Christchurch Centre
We received a total of 30 tests of each variety. Although the sample size is small we can confirm we found exccellentresults when comparing Biotech RapidSTATUS tests to two different alternate test methods/reference laboratories.
Testing was performed strictly as per kit instructions. EDTA whole blood samples were used for the FIV and FIV/FeLV combo tests, and fecal samples for the Giardia tests. Testing was conducted between the time period of the 22nd of February and the 3rd of May 2019.
We tested two known Fel-O-Vax FIV vaccinated adult cats (thier most recent booster vaccinations were received three months prior, and ten months prior). Both tests returned negative on the Biotech RapidSTATUS tests and strongly positive on an alternate FIV/FeLV Snap test, showing no vaccination cross-reaction in Biotech tests.